Clariant to expand Daya Bay

Clariant is to invest CHF 80 million to expand its Care Chemicals facility at Daya Bay in Huizhou, China, by the end of 2024. This will both add capacity for existing products and introduce new products in the pharmaceutical, personal care, home care and industrial sector.

Daya Bay, which has obtained the drug GMP certificate, is the first API site in China certified to produce polyethylene glycol Polyglykol 3350. More generally, it will become new global hub for Clariant’s healthcare business support.

Clariant will also expand existing production capacity for its ethylene oxide derivatives and a broader chemical portfolio at the site, including mild surfactants for personal care applications. Previously, the company had made other investments in the ethoxylation plant, including adding two production lines for halogen-free flame retardants, which are due to open in 2023 and 2024.